All tenders
75N93023C00002
TO CARRY OUT DEVELOPMENT FOR A DRUG CANDIDATE SMALL MOLECULE INHIBITOR AGAINST CHIKUNGUNYA VIRUS, AN ALPHAVIRUS THAT CAUSES DEBILITATING AND SOMETIMES LIFE-THREATENING DISEASE IN HUMANS.
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedEducation & TrainingFederal
Basic information
- Reference number
- 75N93023C00002
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Education & Training
- Title
- TO CARRY OUT DEVELOPMENT FOR A DRUG CANDIDATE SMALL MOLECULE INHIBITOR AGAINST CHIKUNGUNYA VIRUS, AN ALPHAVIRUS THAT CAUSES DEBILITATING AND SOMETIMES LIFE-THREATENING DISEASE IN HUMANS.
- Source
- USASpending (Federal)
- Source ID
- usa-75N93023C00002
Details
- Location
- United States
Description
TO CARRY OUT DEVELOPMENT FOR A DRUG CANDIDATE SMALL MOLECULE INHIBITOR AGAINST CHIKUNGUNYA VIRUS, AN ALPHAVIRUS THAT CAUSES DEBILITATING AND SOMETIMES LIFE-THREATENING DISEASE IN HUMANS. Awarded to: OREGON HEALTH & SCIENCE UNIVERSITY Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2022/11/01 12:00:00 AM UTC
- Closing date
- 2027/05/31 12:00:00 AM UTC
Estimated value
$7.4M USD
Classification
Normalized category
Education & Training